Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q1 2020 · 10-Q
Revenue$0.00$0.00— vs Q1 2019 Net Income-$1.42M-$1.42MN/M vs Q1 2019 EPS Diluted-$0.02-$0.02no prior Q1 2019 on file The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
Operating Cash Flow-$214,775N/M ended Oct 31, 2019 · filed Dec 6, 2019 · 36 d after period end